Literature DB >> 23839939

Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease.

Kirill Bersuker1, Mark S Hipp, Barbara Calamini, Richard I Morimoto, Ron R Kopito.   

Abstract

The cellular heat shock response (HSR) protects cells from toxicity associated with defective protein folding, and this pathway is widely viewed as a potential pharmacological target to treat neurodegenerative diseases linked to protein aggregation. Here we show that the HSR is not activated by mutant huntingtin (HTT) even in cells selected for the highest expression levels and for the presence of inclusion bodies containing aggregated protein. Surprisingly, HSR activation by HSF1 overexpression or by administration of a small molecule activator lowers the concentration threshold at which HTT forms inclusion bodies in cells expressing aggregation-prone, polyglutamine-expanded fragments of HTT. These data suggest that the HSR does not mitigate inclusion body formation.

Entities:  

Keywords:  Flow Cytometry; Heat Shock Protein; Heat Shock Response; Huntington Disease; Molecular Chaperone; Protein Aggregation

Mesh:

Substances:

Year:  2013        PMID: 23839939      PMCID: PMC3745309          DOI: 10.1074/jbc.C113.481945

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.

Authors:  Masahiro Waza; Hiroaki Adachi; Masahisa Katsuno; Makoto Minamiyama; Chen Sang; Fumiaki Tanaka; Akira Inukai; Manabu Doyu; Gen Sobue
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

2.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

3.  Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1.

Authors:  Laura Riva; Martina Koeva; Ferah Yildirim; Leila Pirhaji; Deepika Dinesh; Tali Mazor; Martin L Duennwald; Ernest Fraenkel
Journal:  J Huntingtons Dis       Date:  2012

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease.

Authors:  A Sittler; R Lurz; G Lueder; J Priller; H Lehrach; M K Hayer-Hartl; F U Hartl; E E Wanker
Journal:  Hum Mol Genet       Date:  2001-06-01       Impact factor: 6.150

6.  Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells.

Authors:  D D Mosser; N G Theodorakis; R I Morimoto
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

7.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

8.  Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

Authors:  S W Davies; M Turmaine; B A Cozens; M DiFiglia; A H Sharp; C A Ross; E Scherzinger; E E Wanker; L Mangiarini; G P Bates
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

Review 9.  Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.

Authors:  Yoshitaka Nagai; Nobuhiro Fujikake; H Akiko Popiel; Keiji Wada
Journal:  Curr Pharm Biotechnol       Date:  2010-02       Impact factor: 2.837

10.  Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach.

Authors:  David G Hay; Kirupa Sathasivam; Sönke Tobaben; Bernd Stahl; Michael Marber; Ruben Mestril; Amarbirpal Mahal; Donna L Smith; Ben Woodman; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

View more
  29 in total

Review 1.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

2.  Flow cytometric quantification and characterization of intracellular protein aggregates in yeast.

Authors:  Ayala Shiber; William Breuer; Tommer Ravid
Journal:  Prion       Date:  2014       Impact factor: 3.931

Review 3.  Lymphocyte repertoire selection and intracellular self/non-self-discrimination: historical overview.

Authors:  Donald R Forsdyke
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

Review 4.  Neuropathy- and myopathy-associated mutations in human small heat shock proteins: Characteristics and evolutionary history of the mutation sites.

Authors:  Rainer Benndorf; Jody L Martin; Sergei L Kosakovsky Pond; Joel O Wertheim
Journal:  Mutat Res Rev Mutat Res       Date:  2014-03-06       Impact factor: 5.657

5.  A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.

Authors:  Laura C Bott; Nisha M Badders; Ke-Lian Chen; George G Harmison; Elaine Bautista; Charles C-Y Shih; Masahisa Katsuno; Gen Sobue; J Paul Taylor; Nico P Dantuma; Kenneth H Fischbeck; Carlo Rinaldi
Journal:  Hum Mol Genet       Date:  2016-03-08       Impact factor: 6.150

6.  Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex.

Authors:  Annika Scior; Alexander Buntru; Kristin Arnsburg; Anne Ast; Manuel Iburg; Katrin Juenemann; Maria Lucia Pigazzini; Barbara Mlody; Dmytro Puchkov; Josef Priller; Erich E Wanker; Alessandro Prigione; Janine Kirstein
Journal:  EMBO J       Date:  2017-12-06       Impact factor: 11.598

Review 7.  Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.

Authors:  Sara D Reis; Brígida R Pinho; Jorge M A Oliveira
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

8.  Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.

Authors:  Justin Y Chen; Miloni Parekh; Hadear Seliman; Dariya Bakshinskaya; Wei Dai; Kelvin Kwan; Kuang Yu Chen; Alice Y C Liu
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

Review 9.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

Review 10.  The chaperone Grp78 in protein folding disorders of the nervous system.

Authors:  Julie A Moreno; Evelyn Tiffany-Castiglioni
Journal:  Neurochem Res       Date:  2014-08-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.